XYL
Xylem Inc. NYSE$114.84
Mkt Cap $27.3B
52w Low $114.15
1.7% of range
52w High $154.27
50d MA $123.18
200d MA $136.71
P/E (TTM)
29.4x
EV/EBITDA
18.8x
P/B
2.4x
Debt/Equity
0.2x
ROE
8.9%
P/FCF
36.4x
RSI (14)
—
ATR (14)
—
Beta
1.17
50d MA
$123.18
200d MA
$136.71
Avg Volume
2.3M
About
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 1.09 | 1.12 | +2.8% | 117.91 | -0.1% | -2.1% | +0.2% | -2.2% | -2.6% | -0.9% | — |
| Feb 10, 2026 | TNS | 1.41 | 1.42 | +0.7% | 128.92 | +1.0% | -1.7% | -2.2% | -0.6% | -0.6% | +0.2% | — |
| Oct 28, 2025 | TNS | 1.23 | 1.37 | +11.4% | 150.50 | +1.0% | +1.6% | +0.7% | +0.2% | -0.9% | -0.5% | — |
| Jul 31, 2025 | TNS | 1.15 | 1.26 | +9.6% | 144.62 | -0.6% | -1.7% | -0.4% | -0.7% | -0.7% | -0.8% | — |
| Apr 29, 2025 | TNS | 0.95 | 1.03 | +7.9% | 118.62 | -0.5% | +1.6% | +1.8% | +4.7% | +3.1% | +1.5% | — |
| Feb 4, 2025 | TNS | 1.13 | 1.18 | +4.4% | 129.24 | -0.2% | +0.4% | +1.7% | +1.4% | +1.6% | +2.2% | — |
| Oct 31, 2024 | TNS | 1.11 | 1.11 | +0.0% | 121.78 | -0.3% | -1.9% | -0.8% | +0.4% | +1.6% | +1.5% | — |
| Jul 30, 2024 | TNS | 1.05 | 1.09 | +3.8% | 133.48 | +1.0% | +0.0% | -0.1% | -2.5% | -5.5% | -4.6% | — |
| May 2, 2024 | TNS | 0.84 | 0.90 | +7.3% | 135.99 | +1.1% | +0.9% | +2.4% | +3.0% | +3.8% | +4.9% | — |
| Feb 6, 2024 | TNS | 0.96 | 0.99 | +3.1% | 119.56 | +0.9% | +3.2% | +2.4% | +4.0% | +3.1% | +1.8% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Citigroup | Maintains | Buy → Buy | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | — | — |
| Apr 29 | Stifel | Maintains | Buy → Buy | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | — | — |
| Apr 29 | Barclays | Maintains | Overweight → Overweight | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | — | — |
| Apr 29 | Oppenheimer | Maintains | Outperform → Outperform | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | — | — |
| Apr 29 | UBS | Maintains | Neutral → Neutral | — | $117.91 | $117.79 | -0.1% | -2.1% | +0.2% | -2.2% | — | — |
| Apr 21 | UBS | Downgrade | Buy → Neutral | $132 | $120.46 | $118.67 | -1.5% | -0.4% | +0.8% | +1.0% | +0.8% | +2.5% |
| Apr 16 | JP Morgan | Maintains | Overweight → Overweight | — | $125.19 | $124.96 | -0.2% | +0.0% | -3.3% | -3.8% | -4.2% | -3.0% |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $128.85 | $128.88 | +0.0% | +0.6% | -2.8% | -2.8% | -6.0% | -6.5% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $127.97 | $127.16 | -0.6% | +1.1% | +0.6% | +0.7% | +1.3% | -2.2% |
| Apr 1 | Oppenheimer | Maintains | Outperform → Outperform | — | $119.50 | $120.33 | +0.7% | +2.5% | +1.5% | +3.6% | +4.0% | +7.1% |
Recent Filings
8-K
Xylem Inc -- 8-K Filing
Xylem achieved $2.1 billion in first-quarter 2026 revenue, demonstrating operational strength in its global water solutions business.
Apr 28
8-K · 8.01
!! High
Xylem Inc -- 8-K 8.01: Material Event / Announcement
Xylem Inc received board authorization for a $1.5 billion share repurchase program with no expiration date, allowing management flexibility to return capital to shareholders through open market purchases.
Feb 25
8-K
Xylem Inc -- 8-K Filing
Xylem delivered 6% reported revenue growth to $9.0 billion and raised 2026 guidance to $9.1-$9.2 billion, signaling continued momentum despite moderating organic growth expectations.
Feb 10
Data updated apr 27, 2026 11:02am
· Source: massive.com